MedTrace Logo

Protein Ingestion Before Training Low

NCT03147001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2017-05-10

No results posted yet for this study

Summary

A randomized interventions study using a crossover design. Ten well trained triathletes or bikeriders will be included for to undergo two trail separated by about 3 weeks. The night before the trail each subject will performe a high intense interval trainings session on an ergometer bike. during the night an infusion of aminoacid tracers will be initiated. The subject is woken at 6.30 a.m. Blood samples and a musclebiopsy will be collected prior to the morning bike ride at 8.00a.m. Immediately before the morning bike ride is started the subject will ingest a drink of 0,5g protein or a non-caloric placebo (random order). During the bike ride and the following 4,5 hours blood will be drawn with regular intervals. at time point 0, 60 and 180 min after the training session biopsies are collected.

Conditions

  • Protein Metabolism

Interventions

OTHER

Protein ingestion

A protein drink was ingested prior to the 90min bike ride in one of the completed trails (order randomised).

OTHER

Non-caloric placebo ingestion

A placebo drink was ingested prior to the 90min bike ride in one of the completed trails (order randomised).

Sponsors & Collaborators

  • Arla Foods

    collaborator INDUSTRY

  • Team Denmark

    collaborator OTHER

  • Innovation Fund Denmark

    collaborator INDIV

  • University of Aarhus

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-01-10
Completion
2017-01-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03147001 on ClinicalTrials.gov